MedTrace Logo

Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne

NCT02593383 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 245

Last updated 2019-09-24

No results posted yet for this study

Summary

evaluate the safety and efficacy of Compound Adapalene and Clindamycin Hydrochloride Gel in treatment of chinese patients with acne.

Conditions

Interventions

DRUG

Adapalene + Clindamycin Hydrochloride

0.1% Adapalene + 1% Clindamycin Hydrochloride

DRUG

Adapalene + Clindamycin Hydrochloride

0.1% Adapalene + 2% Clindamycin Hydrochloride

DRUG

Adapalene + Clindamycin Hydrochloride

0.05% Adapalene + 0.5% Clindamycin Hydrochloride

DRUG

Adapalene + Clindamycin Hydrochloride

0.05% Adapalene + 1% Clindamycin Hydrochloride

DRUG

Placebo

Sponsors & Collaborators

  • Lee's Pharmaceutical Limited

    lead INDUSTRY

Principal Investigators

  • Heng GU, MD · Institute of Dermatology, Chinese Academy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-01
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593383 on ClinicalTrials.gov